Dose-Dependent Regulation of NAD(P)H Oxidase Expression by Angiotensin II in Human Endothelial Cells: Protective Effect of Angiotensin II Type 1 Receptor Blockade in Patients With Coronary Artery Disease
Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/01.atv.0000035392.38687.65
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2002
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)